Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.54 - $1.41 $5,681 - $14,836
10,522 New
10,522 $10,000
Q1 2020

May 15, 2020

SELL
$4.62 - $18.74 $61,247 - $248,436
-13,257 Closed
0 $0
Q4 2019

Feb 18, 2020

BUY
$14.6 - $18.13 $193,552 - $240,349
13,257 New
13,257 $224,000
Q2 2019

Aug 14, 2019

SELL
$17.79 - $22.88 $176,085 - $226,466
-9,898 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$11.76 - $22.15 $116,400 - $219,240
9,898 New
9,898 $208,000
Q4 2018

Feb 14, 2019

SELL
$10.42 - $21.94 $142,180 - $299,371
-13,645 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$20.4 - $24.6 $278,358 - $335,667
13,645 New
13,645 $313,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.